Kyle Grimaldi, MD
Emergency Medicine · Charlotte, NCNPI 1639604390
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 14 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 9 manufacturers, the largest accounting for just 23.2% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $151, 10.0 times the $15 reported in 2020.
Across 14 payments — averaging $22.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$72
- Grifols USA, LLC$61
- Stryker$40
- Inari Medical, Inc.$34
- AbbVie$32
- Vertex$28
- plus $41 from 3 others
What the payments were for
- Food & beverage$308100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $72 |
| Grifols USA, LLC | 3 | $61 |
| Stryker | 1 | $40 |
| Inari Medical, Inc. | 1 | $34 |
| AbbVie | 2 | $32 |
| Vertex | 1 | $28 |
| Cook Medical LLC | 1 | $15 |
| Pfizer | 1 | $14 |
| Paratek Pharmaceuticals, Inc. | 1 | $12 |
How this compares
$308 in reported general payments places this provider in the 85th percentile of 1,657 emergency medicine providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cefdinir | 29 | $396 |
| Doxycycline Hyclate | 31 | $240 |
| Ondansetron OdtOndansetron | 45 | $230 |
| Oxycodone Hcl | 50 | $152 |
| Sucralfate | 14 | $109 |
| Cephalexin | 20 | $89 |
| Omeprazole | 14 | $68 |
| Prednisone | 34 | $47 |
Paid to pharmacies, not to this prescriber.
Other emergency medicine in Charlotte
- Boyd WashingtonCharlotte$369K
- Vivek TayalCharlotte$79K
- Bijal ShahCharlotte$45K
- Erik FisherCharlotte$31K
- David SullivanCharlotte$21K
- Sanjay IyerCharlotte$18K
- Elizabeth DunbarCharlotte$12K
- Josie BowenCharlotte$7K
- Andrew AsimosCharlotte$5K
- Harvey MeyersCharlotte$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.